RPG Life Sciences: RPG Life Sciences, engaged in the manufacturing & marketing of pharmaceutical products, posted a jump in profits by 64 per cent YoY and by 16 per cent QoQ for Q3FY21, resulting in maintaining the upward trajectory in EBITDA margins, which improved from 15.8 per cent to 19.9 per cent YoY.